New Treatment for Tough Disease. Researchers at Northwestern University Feinberg School of Medicine found that rosiglitazone, a treatment commonly used in type-2 diabetes, may reduce the severity of scleroderma. (Huliq) The American Journal of Pathology. February 2009. (Also see: Scleroderma Treatments)
This item was posted in the ISN Newsroom. Check the Newsroom every day for the latest scleroderma medical and support information.
New Treatment for Tough Disease
No replies to this topic